Back
MFS Multimarket Income Trust Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
39
MMT
MFS Multimarket Income Trust
Last Price:
4.83
Seasonality Move:
-1.82%
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.13
Seasonality Move:
5.7%
Sell
39
MFS Multimarket Income Trust (MMT)
is a Sell
Is MFS Multimarket Income Trust a Buy, Sell or Hold?
- The current MFS Multimarket Income Trust [MMT] share price is $4.83. The Score for MMT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- MMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $71.14. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MMT Stock Price Chart
What is MFS Multimarket Income Trust's stock price today?
-
The MFS Multimarket Income Trust share price today is $4.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MMT is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $71.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
MMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 60.5 | Buy |
Chaikin Money Flow: | 15819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.76 - 4.82) | Buy |
Bollinger Bands (100): | (4.61 - 4.77) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.61 | Sell |
Relative Strength Index (14 RSI): | 22.64 | Sell |
Chaikin Money Flow: | 871265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.02 - 93.28) | Sell |
Bollinger Bands (100): | (78.57 - 88.29) | Sell |
MMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.82 | Buy |
20-day SMA: | 4.8 | Buy |
50-day SMA: | 4.76 | Buy |
200-day SMA: | 4.64 | Buy |
8-day EMA: | 4.82 | Buy |
20-day EMA: | 4.8 | Buy |
50-day EMA: | 4.76 | Buy |
200-day EMA: | 4.65 | Buy |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 79.35 | Sell |
20-day SMA: | 85.57 | Sell |
50-day SMA: | 85.93 | Sell |
200-day SMA: | 87.02 | Sell |
8-day EMA: | 77.71 | Sell |
20-day EMA: | 82.86 | Sell |
50-day EMA: | 84.86 | Sell |
200-day EMA: | 86.16 | Sell |
MFS Multimarket Income Trust Earnings Growth & MMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
MFS Multimarket Income Trust Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |